2023 Q1 Form 10-K Financial Statement

#000121465923001904 Filed on February 10, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q4 2022
Revenue $6.190M $7.591M $27.79M
YoY Change 2.04% 2.21% 1.81%
Cost Of Revenue $3.939M $4.285M $15.47M
YoY Change 20.24% 7.83% 1.72%
Gross Profit $2.251M $3.306M $12.31M
YoY Change -19.32% -4.26% 1.91%
Gross Profit Margin 36.37% 43.55% 44.31%
Selling, General & Admin $1.806M $1.885M $7.734M
YoY Change 2.15% 3.12% 19.8%
% of Gross Profit 80.23% 57.02% 62.82%
Research & Development $652.0K $657.0K $2.191M
YoY Change 40.52% 35.19% 25.99%
% of Gross Profit 28.96% 19.87% 17.8%
Depreciation & Amortization $103.0K $97.00K $394.0K
YoY Change 5.1% 3.19% 2.6%
% of Gross Profit 4.58% 2.93% 3.2%
Operating Expenses $2.458M $2.542M $9.925M
YoY Change 10.13% 9.85% 21.11%
Operating Profit -$207.0K $764.0K $2.387M
YoY Change -137.1% -32.92% -38.57%
Interest Expense $140.0K $140.0K
YoY Change 636.84% 636.84%
% of Operating Profit 18.32% 5.87%
Other Income/Expense, Net $139.0K $5.000K $972.0K
YoY Change 13800.0% -73.68% -668.42%
Pretax Income -$68.00K $909.0K $3.499M
YoY Change -112.16% -22.77% -6.29%
Income Tax -$12.00K $182.0K $712.0K
% Of Pretax Income 20.02% 20.35%
Net Earnings -$56.00K $727.0K $2.787M
YoY Change -112.07% -25.66% -8.86%
Net Earnings / Revenue -0.9% 9.58% 10.03%
Basic Earnings Per Share -$0.02 $1.08
Diluted Earnings Per Share -$0.02 $0.28 $1.08
COMMON SHARES
Basic Shares Outstanding 2.578M shares 2.578M shares 2.578M shares
Diluted Shares Outstanding 2.578M shares 2.578M shares

Balance Sheet

Concept 2023 Q1 2022 Q4 2022
SHORT-TERM ASSETS
Cash & Short-Term Investments $13.24M $15.38M $15.38M
YoY Change -16.72% 0.81% 0.81%
Cash & Equivalents $13.24M $15.38M $15.38M
Short-Term Investments
Other Short-Term Assets $594.0K $564.0K $564.0K
YoY Change 112.14% 65.4% 65.4%
Inventory $11.34M $10.29M $10.29M
Prepaid Expenses
Receivables $3.532M $4.052M $4.052M
Other Receivables $920.0K $920.0K $920.0K
Total Short-Term Assets $29.63M $31.20M $31.20M
YoY Change 1.08% 4.51% 4.51%
LONG-TERM ASSETS
Property, Plant & Equipment $22.76M $22.46M $22.48M
YoY Change 44.03% 106.01% 106.14%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $86.00K $86.00K $86.00K
YoY Change
Total Long-Term Assets $22.85M $22.56M $22.56M
YoY Change 44.57% 106.92% 106.92%
TOTAL ASSETS
Total Short-Term Assets $29.63M $31.20M $31.20M
Total Long-Term Assets $22.85M $22.56M $22.56M
Total Assets $52.48M $53.76M $53.76M
YoY Change 16.32% 31.91% 31.91%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.469M $1.173M $1.173M
YoY Change -12.82% -40.24% -40.24%
Accrued Expenses $998.0K $1.693M $1.693M
YoY Change 1.53% 0.12% 0.12%
Deferred Revenue
YoY Change
Short-Term Debt $225.0K $224.0K $224.0K
YoY Change
Long-Term Debt Due $225.0K $224.0K $224.0K
YoY Change
Total Short-Term Liabilities $3.363M $4.431M $4.431M
YoY Change -20.78% -12.98% -12.98%
LONG-TERM LIABILITIES
Long-Term Debt $14.63M $14.54M $14.54M
YoY Change 74.57% 331.43% 331.43%
Other Long-Term Liabilities $0.00 $0.00
YoY Change -100.0% -100.0%
Total Long-Term Liabilities $14.63M $14.54M $14.54M
YoY Change 74.57% 329.65% 329.65%
TOTAL LIABILITIES
Total Short-Term Liabilities $3.363M $4.431M $4.431M
Total Long-Term Liabilities $14.63M $14.54M $14.54M
Total Liabilities $18.00M $18.97M $18.97M
YoY Change 42.34% 123.37% 123.37%
SHAREHOLDERS EQUITY
Retained Earnings $34.54M $34.85M
YoY Change 7.82%
Common Stock $308.0K $308.0K
YoY Change 0.0%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.250M $1.250M
YoY Change 0.0%
Treasury Stock Shares 500.0K shares
Shareholders Equity $34.48M $34.80M $34.80M
YoY Change
Total Liabilities & Shareholders Equity $52.48M $53.76M $53.76M
YoY Change 16.32% 31.91% 31.91%

Cashflow Statement

Concept 2023 Q1 2022 Q4 2022
OPERATING ACTIVITIES
Net Income -$56.00K $727.0K $2.787M
YoY Change -112.07% -25.66% -8.86%
Depreciation, Depletion And Amortization $103.0K $97.00K $394.0K
YoY Change 5.1% 3.19% 2.6%
Cash From Operating Activities -$1.493M $655.0K $2.204M
YoY Change -226.96% 25.0% -42.47%
INVESTING ACTIVITIES
Capital Expenditures $480.0K $1.282M $13.21M
YoY Change -109.09% -143.52% -309.43%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$480.0K -$1.282M -$13.21M
YoY Change -90.91% -56.48% 109.43%
FINANCING ACTIVITIES
Cash Dividend Paid $258.0K $258.0K
YoY Change 0.0% 0.0%
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -$158.0K 400.0K $11.13M
YoY Change -103.32% -87.87% 257.83%
NET CHANGE
Cash From Operating Activities -$1.493M 655.0K $2.204M
Cash From Investing Activities -$480.0K -1.282M -$13.21M
Cash From Financing Activities -$158.0K 400.0K $11.13M
Net Change In Cash -$2.131M -227.0K $123.0K
YoY Change -427.34% -125.91% -80.57%
FREE CASH FLOW
Cash From Operating Activities -$1.493M $655.0K $2.204M
Capital Expenditures $480.0K $1.282M $13.21M
Free Cash Flow -$1.973M -$627.0K -$11.01M
YoY Change -130.56% -118.07% -208.57%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022 dei Entity Central Index Key
EntityCentralIndexKey
0000065759
CY2022 dei Amendment Flag
AmendmentFlag
false
CY2022 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2022
CY2022 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
usd
CY2021Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
usd
CY2021Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
usd
CY2022Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2022Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
usd
CY2022 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
usd
CY2021 MPAD Increase In Employee Retention Credits Receivable
IncreaseInEmployeeRetentionCreditsReceivable
usd
CY2022 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
usd
CY2022 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
usd
CY2022Q4 MPAD Interest
Interest
usd
CY2022 dei Document Type
DocumentType
10-K
CY2022 dei Document Annual Report
DocumentAnnualReport
true
CY2022 dei Document Period End Date
DocumentPeriodEndDate
2022-11-30
CY2022 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--11-30
CY2022 dei Document Transition Report
DocumentTransitionReport
false
CY2022 dei Entity File Number
EntityFileNumber
000-5109
CY2022 dei Entity Registrant Name
EntityRegistrantName
Micropac Industries, Inc.
CY2022 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2022 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
75-1225149
CY2022 dei Entity Address Address Line1
EntityAddressAddressLine1
905 E. Walnut Street
CY2022 dei Entity Address City Or Town
EntityAddressCityOrTown
Garland
CY2022 dei Entity Address State Or Province
EntityAddressStateOrProvince
TX
CY2022 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
75040
CY2022 dei City Area Code
CityAreaCode
972
CY2022 dei Local Phone Number
LocalPhoneNumber
272-3571
CY2022 dei Security12b Title
Security12bTitle
Common Stock, $0.10 par value per share
CY2022 dei Trading Symbol
TradingSymbol
MPAD
CY2022 dei Security Exchange Name
SecurityExchangeName
NONE
CY2022 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2022 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2022 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2022 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2022 dei Entity Small Business
EntitySmallBusiness
true
CY2022 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2022 dei Entity Shell Company
EntityShellCompany
false
CY2022Q2 dei Entity Public Float
EntityPublicFloat
9137070 usd
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2578315 shares
CY2022 dei Auditor Name
AuditorName
Whitley Penn LLP
CY2022 dei Auditor Firm
AuditorFirmId
726
CY2022 dei Auditor Location
AuditorLocation
Plano, Texas
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15375000 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15252000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
3644000 usd
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
4974000 usd
CY2022Q4 us-gaap Income Tax Receivable
IncomeTaxReceivable
920000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
408000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
603000 usd
CY2022Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
6715000 usd
CY2021Q4 us-gaap Inventory Raw Materials And Supplies
InventoryRawMaterialsAndSupplies
5738000 usd
CY2022Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
3573000 usd
CY2021Q4 us-gaap Inventory Work In Process And Raw Materials
InventoryWorkInProcessAndRawMaterials
2946000 usd
CY2022Q4 us-gaap Inventory Net
InventoryNet
10288000 usd
CY2021Q4 us-gaap Inventory Net
InventoryNet
8684000 usd
CY2022Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
564000 usd
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
341000 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
31199000 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
29854000 usd
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2578315 shares
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2578315 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
308000 usd
CY2022Q4 us-gaap Land
Land
1518000 usd
CY2021Q4 us-gaap Land
Land
1518000 usd
CY2022Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
498000 usd
CY2021Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
498000 usd
CY2022Q4 us-gaap Inventory Buildings And Improvements
InventoryBuildingsAndImprovements
1126000 usd
CY2021Q4 us-gaap Inventory Buildings And Improvements
InventoryBuildingsAndImprovements
1126000 usd
CY2022Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1036000 usd
CY2021Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
1025000 usd
CY2022Q4 us-gaap Flight Equipment Net
FlightEquipmentNet
19415000 usd
CY2021Q4 us-gaap Flight Equipment Net
FlightEquipmentNet
8019000 usd
CY2022Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
9952000 usd
CY2021Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
9390000 usd
CY2022Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33545000 usd
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
21576000 usd
CY2022Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
11082000 usd
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10739000 usd
CY2022Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
22463000 usd
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
10837000 usd
CY2022Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
14000 usd
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
67000 usd
CY2022Q4 us-gaap Deferred Income Tax Assets Net
DeferredIncomeTaxAssetsNet
86000 usd
CY2022Q4 us-gaap Assets
Assets
53762000 usd
CY2021Q4 us-gaap Assets
Assets
40758000 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1173000 usd
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1963000 usd
CY2022Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1086000 usd
CY2021Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
1295000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
1192000 usd
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
1258000 usd
CY2022Q4 MPAD Property Taxes
PropertyTaxes
560000 usd
CY2021Q4 MPAD Property Taxes
PropertyTaxes
318000 usd
CY2022Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
149000 usd
CY2021Q4 us-gaap Taxes Payable Current
TaxesPayableCurrent
180000 usd
CY2022Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
224000 usd
CY2022Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
47000 usd
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
78000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4431000 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
5092000 usd
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
14000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14535000 usd
CY2021Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
3369000 usd
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
16000 usd
CY2022Q4 us-gaap Liabilities
Liabilities
18966000 usd
CY2021Q4 us-gaap Liabilities
Liabilities
8491000 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
308000 usd
CY2022Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
885000 usd
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.10
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
10000000 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3078315 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3078315 shares
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
885000 usd
CY2022Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
500000 shares
CY2021Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
500000 shares
CY2022Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1250000 usd
CY2021Q4 us-gaap Treasury Stock Value
TreasuryStockValue
1250000 usd
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
34853000 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
32324000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
34796000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
32267000 usd
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
53762000 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
40758000 usd
CY2022 us-gaap Revenues
Revenues
27785000 usd
CY2021 us-gaap Revenues
Revenues
27292000 usd
CY2022 us-gaap Cost Of Revenue
CostOfRevenue
15473000 usd
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
15211000 usd
CY2022 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2191000 usd
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1739000 usd
CY2022 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7734000 usd
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
6456000 usd
CY2022 us-gaap Costs And Expenses
CostsAndExpenses
25398000 usd
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
23406000 usd
CY2022 us-gaap Operating Income Loss
OperatingIncomeLoss
2387000 usd
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
3886000 usd
CY2022 us-gaap Other Income
OtherIncome
972000 usd
CY2021 us-gaap Other Income
OtherIncome
-171000 usd
CY2022 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
140000 usd
CY2021 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
19000 usd
CY2022 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3499000 usd
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3734000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
814000 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
633000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-102000 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
43000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
712000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
676000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2787000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3058000 usd
CY2022 MPAD Net Income Per Share Basic And Diluted
NetIncomePerShareBasicAndDiluted
1.08
CY2021 MPAD Net Income Per Share Basic And Diluted
NetIncomePerShareBasicAndDiluted
1.19
CY2022 MPAD Weighted Average Of Shares Basic And Diluted
WeightedAverageOfSharesBasicAndDiluted
2578315 shares
CY2021 MPAD Weighted Average Of Shares Basic And Diluted
WeightedAverageOfSharesBasicAndDiluted
2578315 shares
CY2022 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.10
CY2021 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.10
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
29467000 usd
CY2021 us-gaap Dividends
Dividends
258000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3058000 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
32267000 usd
CY2022 us-gaap Dividends
Dividends
258000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2787000 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
34796000 usd
CY2022 us-gaap Net Income Loss
NetIncomeLoss
2787000 usd
CY2021 us-gaap Net Income Loss
NetIncomeLoss
3058000 usd
CY2022 us-gaap Depreciation
Depreciation
394000 usd
CY2021 us-gaap Depreciation
Depreciation
384000 usd
CY2022 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
102000 usd
CY2021 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-43000 usd
CY2021 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-245000 usd
CY2022 MPAD Increase Decreasein Right Useof Asset
IncreaseDecreaseinRightUseofAsset
-53000 usd
CY2021 MPAD Increase Decreasein Right Useof Asset
IncreaseDecreaseinRightUseofAsset
-50000 usd
CY2022 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-1330000 usd
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
2334000 usd
CY2022 MPAD Increase In Employee Retention Credits Receivable
IncreaseInEmployeeRetentionCreditsReceivable
920000 usd
CY2022 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-195000 usd
CY2021 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
91000 usd
CY2022 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1604000 usd
CY2021 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-452000 usd
CY2022 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
223000 usd
CY2021 us-gaap Increase Decrease In Prepaid Expenses Other
IncreaseDecreaseInPrepaidExpensesOther
-174000 usd
CY2021 us-gaap Increase Decrease In Prepaid Taxes
IncreaseDecreaseInPrepaidTaxes
-223000 usd
CY2022 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-66000 usd
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
1146000 usd
CY2022 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
403000 usd
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-101000 usd
CY2022 MPAD Accrued Compensation
AccruedCompensation
209000 usd
CY2021 MPAD Accrued Compensation
AccruedCompensation
-314000 usd
CY2022 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-30000 usd
CY2021 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
156000 usd
CY2022 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-53000 usd
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-50000 usd
CY2022 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
249000 usd
CY2021 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
162000 usd
CY2022 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
2204000 usd
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3831000 usd
CY2022 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
13213000 usd
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6309000 usd
CY2022 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-13213000 usd
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6309000 usd
CY2022 us-gaap Payments Of Dividends
PaymentsOfDividends
258000 usd
CY2021 us-gaap Payments Of Dividends
PaymentsOfDividends
258000 usd
CY2022 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
11390000 usd
CY2021 us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3548000 usd
CY2021 us-gaap Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
179000 usd
CY2022 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
11132000 usd
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3111000 usd
CY2022 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
123000 usd
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
633000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15252000 usd
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14619000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15375000 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
15252000 usd
CY2022 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
845000 usd
CY2021 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
472000 usd
CY2022 MPAD Accrued Additions Property Plant Equipment
AccruedAdditionsPropertyPlantEquipment
44000 usd
CY2021 MPAD Accrued Additions Property Plant Equipment
AccruedAdditionsPropertyPlantEquipment
1221000 usd
CY2022 us-gaap Revenues
Revenues
27785000 usd
CY2021 us-gaap Revenues
Revenues
27292000 usd
CY2022 us-gaap Revenues
Revenues
27785000 usd
CY2021 us-gaap Revenues
Revenues
27292000 usd
CY2022 MPAD Domestic Direct
DomesticDirect
16433000 usd
CY2022 MPAD Domestic Distrbution
DomesticDistrbution
10330000 usd
CY2022 MPAD International Distribution
InternationalDistribution
1022000 usd
CY2022 us-gaap Revenues
Revenues
27785000 usd
CY2021 MPAD Domestic Direct
DomesticDirect
16640000 usd
CY2021 MPAD Domestic Distrbution
DomesticDistrbution
9450000 usd
CY2021 MPAD International Distribution
InternationalDistribution
1202000 usd
CY2021 us-gaap Revenues
Revenues
27292000 usd
CY2022Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
3644000 usd
CY2021Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
4974000 usd
CY2019Q4 us-gaap Receivables Net Current
ReceivablesNetCurrent
2639000 usd
CY2022Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
408000 usd
CY2021Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
603000 usd
CY2019Q4 us-gaap Contract With Customer Asset Net Current
ContractWithCustomerAssetNetCurrent
512000 usd
CY2022Q4 us-gaap Deferred Revenue
DeferredRevenue
1192000 usd
CY2021Q4 us-gaap Deferred Revenue
DeferredRevenue
1258000 usd
CY2019Q4 us-gaap Deferred Revenue
DeferredRevenue
111000 usd
CY2022 MPAD Deferred Revenue Recognized
DeferredRevenueRecognized
103000 usd
CY2022 MPAD Dilutive Potential Coommon Stock Instruments
DilutivePotentialCoommonStockInstruments
0 shares
CY2021 MPAD Dilutive Potential Coommon Stock Instruments
DilutivePotentialCoommonStockInstruments
0 shares
CY2022 us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_845_eus-gaap--UseOfEstimates_z8KKJDXtz18b" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b><span style="text-decoration: underline"><span id="xdx_863_zHw8Y3PXvki9">Use of Estimates</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify; text-indent: 0in">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</p>
CY2022Q4 MPAD Fair Value Financial Assets Liabilities Recurring Basis
FairValueFinancialAssetsLiabilitiesRecurringBasis
0 usd
CY2021Q4 MPAD Fair Value Financial Assets Liabilities Recurring Basis
FairValueFinancialAssetsLiabilitiesRecurringBasis
0 usd
CY2022Q4 MPAD Fair Value Non Financial Assets Non Recurring Basis
FairValueNonFinancialAssetsNonRecurringBasis
0 usd
CY2021Q4 MPAD Fair Value Non Financial Assets Non Recurring Basis
FairValueNonFinancialAssetsNonRecurringBasis
0 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
14938000 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
14938000 usd
CY2022Q4 us-gaap Unamortized Debt Issuance Expense
UnamortizedDebtIssuanceExpense
179000 usd
CY2022Q4 MPAD Net Debt
NetDebt
14759000 usd
CY2022Q4 us-gaap Debt Current
DebtCurrent
224000 usd
CY2022Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
14535000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Next Twelve Months
LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths
224000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Two
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo
395000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Three
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree
407000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Four
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour
421000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal In Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive
436000 usd
CY2022Q4 us-gaap Long Term Debt Maturities Repayments Of Principal After Year Five
LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive
13057000 usd
CY2022Q4 us-gaap Long Term Debt
LongTermDebt
14938000 usd
CY2022 us-gaap Product Warranty Expense
ProductWarrantyExpense
114000 usd
CY2021 us-gaap Product Warranty Expense
ProductWarrantyExpense
185000 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
25000 usd
CY2020Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
60000 usd
CY2022 us-gaap Product Warranty Accrual Additions From Business Acquisition
ProductWarrantyAccrualAdditionsFromBusinessAcquisition
114000 usd
CY2021 us-gaap Product Warranty Accrual Additions From Business Acquisition
ProductWarrantyAccrualAdditionsFromBusinessAcquisition
56000 usd
CY2022 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
114000 usd
CY2021 us-gaap Product Warranty Accrual Payments
ProductWarrantyAccrualPayments
91000 usd
CY2022Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
25000 usd
CY2021Q4 us-gaap Product Warranty Accrual
ProductWarrantyAccrual
25000 usd
CY2022Q4 MPAD Rent Expense
RentExpense
55000 usd
CY2021Q4 MPAD Rent Expense
RentExpense
52000 usd
CY2021Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
165000 usd
CY2021Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
165000 usd
CY2022 us-gaap Operating Lease Expense
OperatingLeaseExpense
55000 usd
CY2022Q4 us-gaap Long Term Debt Percentage Bearing Fixed Interest Rate
LongTermDebtPercentageBearingFixedInterestRate
0.0325 pure
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
14000 usd
CY2022Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
14000 usd
CY2022Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
14000 usd
CY2022 MPAD Percentage Of Employee Contributions To The Plan Are Matched By The Company At The Amounts Of The Participants Salary
PercentageOfEmployeeContributionsToThePlanAreMatchedByTheCompanyAtTheAmountsOfTheParticipantsSalary
0.06 pure
CY2021 MPAD Percentage Of Employee Contributions To The Plan Are Matched By The Company At The Amounts Of The Participants Salary
PercentageOfEmployeeContributionsToThePlanAreMatchedByTheCompanyAtTheAmountsOfTheParticipantsSalary
0.06 pure
CY2022Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
476000 usd
CY2021Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
421000 usd
CY2022Q4 MPAD Employees Become Vested In Company Contributions After Two Years
EmployeesBecomeVestedInCompanyContributionsAfterTwoYears
0.20 pure
CY2021Q4 MPAD Employees Become Vested In Company Contributions After Two Years
EmployeesBecomeVestedInCompanyContributionsAfterTwoYears
0.20 pure
CY2022 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
744000 usd
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
574000 usd
CY2022 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
700000 usd
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
59000 usd
CY2022 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
814000 usd
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
633000 usd
CY2022 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-102000 usd
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
43000 usd
CY2022 us-gaap Provision For Other Losses
ProvisionForOtherLosses
712000 usd
CY2021 us-gaap Provision For Other Losses
ProvisionForOtherLosses
676000 usd
CY2022 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
734000 usd
CY2021 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
784000 usd
CY2022 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
55000 usd
CY2021 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
46000 usd
CY2022 MPAD Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
156000 usd
CY2021 MPAD Research And Development Tax Credit
ResearchAndDevelopmentTaxCredit
197000 usd
CY2022 MPAD Permanent Differences And Other
PermanentDifferencesAndOther
79000 usd
CY2021 MPAD Permanent Differences And Other
PermanentDifferencesAndOther
43000 usd
CY2022 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
712000 usd
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
676000 usd
CY2022Q4 us-gaap Inventory Gross
InventoryGross
265000 usd
CY2021Q4 us-gaap Inventory Gross
InventoryGross
169000 usd
CY2022Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
5000 usd
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Returns And Allowances
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReturnsAndAllowances
5000 usd
CY2022Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
83000 usd
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
52000 usd
CY2022Q4 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
267000 usd
CY2021Q4 us-gaap Property Plant And Equipment Other Accumulated Depreciation
PropertyPlantAndEquipmentOtherAccumulatedDepreciation
242000 usd
CY2022Q4 MPAD Net Deferred Tax Assets Liabilities
NetDeferredTaxAssetsLiabilities
86000 usd
CY2021Q4 MPAD Net Deferred Tax Assets Liabilities
NetDeferredTaxAssetsLiabilities
-16000 usd
CY2022Q4 MPAD Sale To Government
SaleToGovernment
0.77 pure
CY2021Q4 MPAD Sale To Government
SaleToGovernment
0.67 pure
CY2021 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2020-12-08
CY2021 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.10
CY2021 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2021-01-06
CY2021 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2021-02-12
CY2022 us-gaap Dividends Payable Date Declared Day Month And Year
DividendsPayableDateDeclaredDayMonthAndYear
2021-12-07
CY2022 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.10
CY2022 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2022-01-11
CY2022 us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2022-02-10
CY2021Q1 MPAD Employee Retention Credits
EmployeeRetentionCredits
920000 usd

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0001214659-23-001904-index-headers.html Edgar Link pending
0001214659-23-001904-index.html Edgar Link pending
0001214659-23-001904.txt Edgar Link pending
0001214659-23-001904-xbrl.zip Edgar Link pending
d2823110k.htm Edgar Link pending
ex31_1.htm Edgar Link pending
ex31_2.htm Edgar Link pending
ex32_1.htm Edgar Link pending
ex32_2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
mpad-20221130.xsd Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
mpad-20221130_cal.xml Edgar Link unprocessable
mpad-20221130_def.xml Edgar Link unprocessable
mpad-20221130_lab.xml Edgar Link unprocessable
mpad-20221130_pre.xml Edgar Link unprocessable
d2823110k_htm.xml Edgar Link completed
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending